Found: 47
Select item for more details and to access through your institution.
Androgen receptor gene expression in primary breast cancer.
- Published in:
- NPJ Breast Cancer, 2019, v. 5, n. 1, p. 1, doi. 10.1038/s41523-019-0142-6
- By:
- Publication type:
- Article
Suppression of FOXM1 activities and breast cancer growth in vitro and in vivo by a new class of compounds.
- Published in:
- NPJ Breast Cancer, 2019, v. 5, n. 1, p. N.PAG, doi. 10.1038/s41523-019-0141-7
- By:
- Publication type:
- Article
Response to Olaparib in a Patient with Germline BRCA2 Mutation and Breast Cancer Leptomeningeal Carcinomatosis.
- Published in:
- NPJ Breast Cancer, 2019, v. 5, n. 1, p. N.PAG, doi. 10.1038/s41523-019-0139-1
- By:
- Publication type:
- Article
Publisher Correction: Homologous recombination DNA repair defects in PALB2-associated breast cancers.
- Published in:
- 2019
- By:
- Publication type:
- Correction Notice
Application of convolutional neural networks to breast biopsies to delineate tissue correlates of mammographic breast density.
- Published in:
- NPJ Breast Cancer, 2019, v. 5, n. 1, p. N.PAG, doi. 10.1038/s41523-019-0134-6
- By:
- Publication type:
- Article
Menstrual cycle associated changes in hormone-related gene expression in oestrogen receptor positive breast cancer.
- Published in:
- NPJ Breast Cancer, 2019, v. 5, n. 1, p. N.PAG, doi. 10.1038/s41523-019-0138-2
- By:
- Publication type:
- Article
Ten-year clinical outcomes in N0 ER+ breast cancer patients with Recurrence Score-guided therapy.
- Published in:
- NPJ Breast Cancer, 2019, v. 5, n. 1, p. N.PAG, doi. 10.1038/s41523-019-0137-3
- By:
- Publication type:
- Article
Evidence for a causal role by mouse mammary tumour-like virus in human breast cancer.
- Published in:
- NPJ Breast Cancer, 2019, v. 5, n. 1, p. N.PAG, doi. 10.1038/s41523-019-0136-4
- By:
- Publication type:
- Article
Retinoid X receptor agonist LG100268 modulates the immune microenvironment in preclinical breast cancer models.
- Published in:
- NPJ Breast Cancer, 2019, v. 5, n. 1, p. N.PAG, doi. 10.1038/s41523-019-0135-5
- By:
- Publication type:
- Article
The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer.
- Published in:
- NPJ Breast Cancer, 2019, v. 5, n. 1, p. N.PAG, doi. 10.1038/s41523-019-0127-5
- By:
- Publication type:
- Article
If we build it they will come: targeting the immune response to breast cancer.
- Published in:
- NPJ Breast Cancer, 2019, v. 5, n. 1, p. N.PAG, doi. 10.1038/s41523-019-0133-7
- By:
- Publication type:
- Article
Randomized phase-II evaluation of letrozole plus dasatinib in hormone receptor positive metastatic breast cancer patients.
- Published in:
- NPJ Breast Cancer, 2019, v. 5, n. 1, p. N.PAG, doi. 10.1038/s41523-019-0132-8
- By:
- Publication type:
- Article
Wnt5a induces ROR1 to recruit cortactin to promote breast-cancer migration and metastasis.
- Published in:
- NPJ Breast Cancer, 2019, v. 5, n. 1, p. N.PAG, doi. 10.1038/s41523-019-0131-9
- By:
- Publication type:
- Article
Two may be better than one: PD-1/PD-L1 blockade combination approaches in metastatic breast cancer.
- Published in:
- NPJ Breast Cancer, 2019, v. 5, n. 1, p. N.PAG, doi. 10.1038/s41523-019-0130-x
- By:
- Publication type:
- Article
Obesity and survival among a cohort of breast cancer patients is partially mediated by tumor characteristics.
- Published in:
- NPJ Breast Cancer, 2019, v. 5, n. 1, p. N.PAG, doi. 10.1038/s41523-019-0128-4
- By:
- Publication type:
- Article
Oncotype DX recurrence score implications for disparities in chemotherapy and breast cancer mortality in Georgia.
- Published in:
- NPJ Breast Cancer, 2019, v. 5, n. 1, p. N.PAG, doi. 10.1038/s41523-019-0129-3
- By:
- Publication type:
- Article
PIK3CA and MAP3K1 alterations imply luminal A status and are associated with clinical benefit from pan-PI3K inhibitor buparlisib and letrozole in ER+ metastatic breast cancer.
- Published in:
- NPJ Breast Cancer, 2019, v. 5, n. 1, p. N.PAG, doi. 10.1038/s41523-019-0126-6
- By:
- Publication type:
- Article
Robust and interpretable PAM50 reclassification exhibits survival advantage for myoepithelial and immune phenotypes.
- Published in:
- NPJ Breast Cancer, 2019, v. 5, n. 1, p. N.PAG, doi. 10.1038/s41523-019-0124-8
- By:
- Publication type:
- Article
Success rates of re-excision after positive margins for invasive lobular carcinoma of the breast.
- Published in:
- NPJ Breast Cancer, 2019, v. 5, n. 1, p. N.PAG, doi. 10.1038/s41523-019-0125-7
- By:
- Publication type:
- Article
Metabolomic analysis of serum may refine 21-gene expression assay risk recurrence stratification.
- Published in:
- NPJ Breast Cancer, 2019, v. 5, n. 1, p. N.PAG, doi. 10.1038/s41523-019-0123-9
- By:
- Publication type:
- Article
Quantitative assessments and clinical outcomes in HER2 equivocal 2018 ASCO/CAP ISH group 4 breast cancer.
- Published in:
- NPJ Breast Cancer, 2019, v. 5, n. 1, p. N.PAG, doi. 10.1038/s41523-019-0122-x
- By:
- Publication type:
- Article
Are all cyclin-dependent kinases 4/6 inhibitors created equal?
- Published in:
- NPJ Breast Cancer, 2019, v. 5, n. 1, p. N.PAG, doi. 10.1038/s41523-019-0121-y
- By:
- Publication type:
- Article
De-escalation yes, but not at the expense of efficacy: in defense of better treatment.
- Published in:
- NPJ Breast Cancer, 2019, v. 5, n. 1, p. N.PAG, doi. 10.1038/s41523-019-0120-z
- By:
- Publication type:
- Article
Adjuvant chemotherapy for node negative, high Recurrence Score<sup>TM</sup> breast cancer: in defense of de-escalation.
- Published in:
- NPJ Breast Cancer, 2019, v. 5, n. 1, p. N.PAG, doi. 10.1038/s41523-019-0119-5
- By:
- Publication type:
- Article
Homologous recombination DNA repair defects in PALB2-associated breast cancers.
- Published in:
- NPJ Breast Cancer, 2019, v. 5, n. 1, p. N.PAG, doi. 10.1038/s41523-019-0115-9
- By:
- Publication type:
- Article
Heterocellular gene signatures reveal luminal-A breast cancer heterogeneity and differential therapeutic responses.
- Published in:
- NPJ Breast Cancer, 2019, v. 5, n. 1, p. N.PAG, doi. 10.1038/s41523-019-0116-8
- By:
- Publication type:
- Article
The phosphatase PPM1A inhibits triple negative breast cancer growth by blocking cell cycle progression.
- Published in:
- NPJ Breast Cancer, 2019, v. 5, n. 1, p. N.PAG, doi. 10.1038/s41523-019-0118-6
- By:
- Publication type:
- Article
Clinicopathological and epidemiological significance of breast cancer subtype reclassification based on p53 immunohistochemical expression.
- Published in:
- NPJ Breast Cancer, 2019, v. 5, n. 1, p. N.PAG, doi. 10.1038/s41523-019-0117-7
- By:
- Publication type:
- Article
FGFR4 overexpression and hotspot mutations in metastatic ER+ breast cancer are enriched in the lobular subtype.
- Published in:
- NPJ Breast Cancer, 2019, v. 5, n. 1, p. N.PAG, doi. 10.1038/s41523-019-0114-x
- By:
- Publication type:
- Article
LobSig is a multigene predictor of outcome in invasive lobular carcinoma.
- Published in:
- NPJ Breast Cancer, 2019, v. 5, n. 1, p. N.PAG, doi. 10.1038/s41523-019-0113-y
- By:
- Publication type:
- Article
A case report of vanishing bile duct syndrome after exposure to pexidartinib (PLX3397) and paclitaxel.
- Published in:
- NPJ Breast Cancer, 2019, v. 5, n. 1, p. N.PAG, doi. 10.1038/s41523-019-0112-z
- By:
- Publication type:
- Article
SET<sub>ER/PR</sub>: a robust 18-gene predictor for sensitivity to endocrine therapy for metastatic breast cancer.
- Published in:
- NPJ Breast Cancer, 2019, v. 5, n. 1, p. N.PAG, doi. 10.1038/s41523-019-0111-0
- By:
- Publication type:
- Article
Estrogen receptor variants in ER-positive basal-type breast cancers responding to therapy like ER-negative breast cancers.
- Published in:
- NPJ Breast Cancer, 2019, v. 5, n. 1, p. N.PAG, doi. 10.1038/s41523-019-0109-7
- By:
- Publication type:
- Article
Initial experience of dedicated breast PET imaging of ER+ breast cancers using [F-18]fluoroestradiol.
- Published in:
- NPJ Breast Cancer, 2019, v. 5, n. 1, p. N.PAG, doi. 10.1038/s41523-019-0107-9
- By:
- Publication type:
- Article
Therapeutic targeting of BRCA1 and TP53 mutant breast cancer through mutant p53 reactivation.
- Published in:
- NPJ Breast Cancer, 2019, v. 5, n. 1, p. N.PAG, doi. 10.1038/s41523-019-0110-1
- By:
- Publication type:
- Article
Simultaneous defeat of MCF7 and MDA-MB-231 resistances by a hypericin PDT–tamoxifen hybrid therapy.
- Published in:
- NPJ Breast Cancer, 2019, v. 5, n. 1, p. N.PAG, doi. 10.1038/s41523-019-0108-8
- By:
- Publication type:
- Article
NDRG4 promoter hypermethylation is a mechanistic biomarker associated with metastatic progression in breast cancer patients.
- Published in:
- NPJ Breast Cancer, 2019, v. 5, n. 1, p. N.PAG, doi. 10.1038/s41523-019-0106-x
- By:
- Publication type:
- Article
AKT1<sup>low</sup> quiescent cancer cells in ductal carcinoma in situ of the breast.
- Published in:
- NPJ Breast Cancer, 2019, v. 5, n. 1, p. N.PAG, doi. 10.1038/s41523-019-0105-y
- By:
- Publication type:
- Article
ESR1 mutations in metastatic lobular breast cancer patients.
- Published in:
- NPJ Breast Cancer, 2019, v. 5, n. 1, p. N.PAG, doi. 10.1038/s41523-019-0104-z
- By:
- Publication type:
- Article
Supporting data sharing.
- Published in:
- 2019
- By:
- Publication type:
- Editorial
pAKT pathway activation is associated with PIK3CA mutations and good prognosis in luminal breast cancer in contrast to p-mTOR pathway activation.
- Published in:
- NPJ Breast Cancer, 2019, v. 5, n. 1, p. N.PAG, doi. 10.1038/s41523-019-0102-1
- By:
- Publication type:
- Article
Assessment of HMGA2 and PLAG1 rearrangements in breast adenomyoepitheliomas.
- Published in:
- NPJ Breast Cancer, 2019, v. 5, n. 1, p. N.PAG, doi. 10.1038/s41523-018-0101-7
- By:
- Publication type:
- Article
MONARCH 3 final PFS: a randomized study of abemaciclib as initial therapy for advanced breast cancer.
- Published in:
- NPJ Breast Cancer, 2019, v. 5, n. 1, p. N.PAG, doi. 10.1038/s41523-018-0097-z
- By:
- Publication type:
- Article
Dual endothelin receptor inhibition enhances T-DM1 efficacy in brain metastases from HER2-positive breast cancer.
- Published in:
- NPJ Breast Cancer, 2019, v. 5, n. 1, p. N.PAG, doi. 10.1038/s41523-018-0100-8
- By:
- Publication type:
- Article
Fructosamine and diabetes as predictors of mortality among Hispanic and non-Hispanic white breast cancer survivors.
- Published in:
- NPJ Breast Cancer, 2019, v. 5, n. 1, p. N.PAG, doi. 10.1038/s41523-018-0099-x
- By:
- Publication type:
- Article
PERSEPHONE: are we ready to de-escalate adjuvant trastuzumab for HER2-positive breast cancer?
- Published in:
- NPJ Breast Cancer, 2019, v. 5, n. 1, p. N.PAG, doi. 10.1038/s41523-018-0098-y
- By:
- Publication type:
- Article
Author Correction: Surgical Standards for Management of the Axilla in Breast Cancer Clinical Trials with Pathological Complete Response Endpoint.
- Published in:
- 2019
- By:
- Publication type:
- Correction Notice